The deal priced below last closing price of $14.02. Goldman Sachs, TD Cowen and Leerink are acting as joint book running managers for the offering.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SGMT:
- Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock
- Sagimet Biosciences Announces Proposed Public Offering of Series A Common Stock
- Sagimet Biosciences files to sell 9M shares of Series A common stock
- Sagimet Biosciences price target raised to $47 from $31 at JMP Securities
- Sagimet Biosciences Stock (NASDAQ:SGMT): Don’t Get Squeezed Out of Your Money